Paper29323716
Oxidative burden in familial hypercholesterolemia.
Mollazadeh H and 4 others. J Cell Physiol, 2018. Cited by 37 papers, by iCite.
Cite this record
ConductScience Library. Oxidative burden in familial hypercholesterolemia. Papers, record 29323716. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29323716
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hyperlipoproteinemia Type II | Major topic |
| Oxidative Stress | Major topic |
| Animals | |
| Atherosclerosis | |
| Cholesterol, LDL | |
| Humans | |
| Lipoproteins, LDL | |
| Oxidation-Reduction | |
| Reactive Oxygen Species |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39857597 | Lipid Profiles, Telomere Length, and the Risk of Malignant Tumors: A Mendelian Randomization and Mediation Analysis. | Biomedicines | 2024 | https://conductscience.org/library/papers/39857597 | PubMed |
| 38790617 | Lipid Oxidation Products and the Risk of Cardiovascular Diseases: Role of Lipoprotein Transport. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/38790617 | PubMed |
| 37873768 | Studies on the Effects of Hypercholesterolemia on Mouse Ophthalmic Artery Reactivity. | Diseases | 2023 | https://conductscience.org/library/papers/37873768 | PubMed |
| 37714962 | Understanding mechanisms of antioxidant action in health and disease. | Nat Rev Mol Cell Biol | 2024 | https://conductscience.org/library/papers/37714962 | PubMed |
| 37637934 | Increased extracellular vesicles (EVs) related to T cell-mediated inflammation and vascular function in familial hypercholesterolemia. | Atheroscler Plus | 2023 | https://conductscience.org/library/papers/37637934 | PubMed |
| 37248472 | GRP78/BiP alleviates oxLDL-induced hepatotoxicity in familial hypercholesterolemia caused by missense variants of LDLR in a HepG2 cellular model. | Lipids Health Dis | 2023 | https://conductscience.org/library/papers/37248472 | PubMed |
| 37180899 | Beyond mechanical loading: The metabolic contribution of obesity in osteoarthritis unveils novel therapeutic targets. | Heliyon | 2023 | https://conductscience.org/library/papers/37180899 | PubMed |
| 37153376 | Serum paraoxonase activity in familial hypercholesterolaemia. | Arch Med Sci Atheroscler Dis | 2023 | https://conductscience.org/library/papers/37153376 | PubMed |
| 36978827 | Treatment with PCSK9 Inhibitor Evolocumab Improves Vascular Oxidative Stress and Arterial Stiffness in Hypercholesterolemic Patients with High Cardiovascular Risk. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/36978827 | PubMed |
| 36290587 | Intraocular Pressure-Induced Endothelial Dysfunction of Retinal Blood Vessels Is Persistent, but Does Not Trigger Retinal Ganglion Cell Loss. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/36290587 | PubMed |
| 35590369 | SORBS2 as a molecular target for atherosclerosis in patients with familial hypercholesterolemia. | J Transl Med | 2022 | https://conductscience.org/library/papers/35590369 | PubMed |
| 35094287 | ICT1 deficiency leads to reduced oxygen resistance due to the cell wall damage in S. cerevisiae. | Genes Genomics | 2022 | https://conductscience.org/library/papers/35094287 | PubMed |
| 34945165 | Evaluation of Oxidative Stress Status in Familial Hypercholesterolemia. | J Clin Med | 2021 | https://conductscience.org/library/papers/34945165 | PubMed |
| 34898989 | Biological Functions and Activities of Rice Bran as a Functional Ingredient: A Review. | Nutr Metab Insights | 2021 | https://conductscience.org/library/papers/34898989 | PubMed |
| 34832328 | ROS-Based Nanoparticles for Atherosclerosis Treatment. | Materials (Basel) | 2021 | https://conductscience.org/library/papers/34832328 | PubMed |
| 34299655 | Targeting Inflammation by Anthocyanins as the Novel Therapeutic Potential for Chronic Diseases: An Update. | Molecules | 2021 | https://conductscience.org/library/papers/34299655 | PubMed |
| 34071103 | Antiplatelet Effects of PCSK9 Inhibitors in Primary Hypercholesterolemia. | Life (Basel) | 2021 | https://conductscience.org/library/papers/34071103 | PubMed |
| 33178827 | Thymoquinone Protects against Hyperlipidemia-Induced Cardiac Damage in Low-Density Lipoprotein Receptor-Deficient (LDL-R-/-) Mice via Its Anti-inflammatory and Antipyroptotic Effects. | Biomed Res Int | 2020 | https://conductscience.org/library/papers/33178827 | PubMed |
| 33158089 | Monitoring the Effects of Hypolipidemic Treatment in Children with Familial Hypercholesterolemia in Poland. | Life (Basel) | 2020 | https://conductscience.org/library/papers/33158089 | PubMed |
| 32179241 | Anthocyanin supplementation improves anti-oxidative and anti-inflammatory capacity in a dose-response manner in subjects with dyslipidemia. | Redox Biol | 2020 | https://conductscience.org/library/papers/32179241 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| LDLR | 3949 | PubTator's text mining | https://conductscience.org/library/genes/3949 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29323716
GET https://conductscience.org/api/papers/v1/29323716/cited_by?page=2